Zentek Ltd. (V:ZEN*CA)

Business Focus: Biotechnology & Medical Research (NEC)

Sector:  Healthcare Industry:  Biotechnology & Medical Research
 
Company Contact
Address: 24 Corporate Ct
GUELPH ON N1G 5G5
Tel: N/A
Website: https://www.zentek.com
IR: See website
<
Key People
Gregory Fenton
Chief Executive Officer, Director
Wendy Ford
Chief Financial Officer
Francis Dube
Chief Operating Officer, Director
Colin Van Der Kuur
Vice President - Science and Research
Ryan Shacklock
Vice President - Strategy, Business Development and Investor Relations
 
Business Overview
Zentek Ltd. is a Canada-based graphene technology company. The principal business of the Company is to develop opportunities in the graphene and related nano-materials industry based on its intellectual property, patents and unique Albany graphite. The Company is focused on the research, development, and commercialization of graphene-based products. The Company's technology helps filter and deactivate pathogens to reduce the risk of transmission. The Company is focused on commercializing ZenGUARD, which is a hydrophilic, water attracting coating that adsorbs bacteria and virus-laden aerosols and deactivates them, increasing public safety, and reducing the risk of transmission of COVID and other pathogens. The Company is developing a graphene-based fuel additive that can reduce greenhouse gas (GHG) emissions from diesel and bio-diesel fuels. The Company's developments include Aptamers & Rapid Detection and Graphene-Oxide Synthesis & Graphene Synthesis.
Financial Overview
For the nine months ended 31 December 2023, Zentek Ltd revenues decreased 62% to C$24K. Net loss decreased 21% to C$9.2M. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Lower net loss reflects Share-based compensation decrease of 48% to C$1.6M (expense), Consulting fees decrease of 53% to C$431K (expense), Government grants increase from C$21K to C$343K (income).
Employees: 27 as of Mar 31, 2023
Reporting Currency: Canadian Dollars
Enterprise value: $136.96M as of Dec 31, 2023
Annual revenue (TTM): $0.03M as of Dec 31, 2023
EBITDA (TTM): -$12.33M as of Dec 31, 2023
Net annual income (TTM): -$11.98M as of Dec 31, 2023
Free cash flow (TTM): -$10.16M as of Dec 31, 2023
Net Debt Last Fiscal Year: N/A
Shares outstanding: 100,819,577 as of Feb 12, 2024
TTM: Trailing Twelve Months
EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please log in or subscribe.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.